Re-engagement and Engagement in Treatment for Antiretroviral Interrupted and Naïve Populations (RETAIN) is BC-CfE initiative that aims to reach patients who have stopped accessing HIV treatment and care by linking these individuals to outreach teams across the province.
An HIV prevention program, available at no cost to people at high risk of HIV, is enrolling over 400 participants Ð primarily men who have sex with men (MSM) Ð every month right across BC. PrEP (pre-exposure prophylaxis) is a daily oral antiretroviral medication that prevents new HIV infection when taken consistently.
Spring ARV Update: Publicly-funded PrEP off to strong start in BC Read More »
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
